Impact News +++ Amazon is Considering a $9 Billion Deal to Acquire Satellite Communications Company Globalstar. Here′s Why... (Fool) +++ GLOBALSTAR Aktie +3,82%

REZOLUTE Aktie

>REZOLUTE Aktienkurs

2.69 EUR (TradegateBSX)

Ask: 2.74 EUR / 3700 Stück

Bid: 2.64 EUR / 7300 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

REZOLUTE Aktie über LYNX handeln

Intraday

1 Jahr

>REZOLUTE Performance

1 Woche: +1,5%

1 Monat: +4,7%

3 Monate: +27,4%

6 Monate: -65,6%

1 Jahr: 0%

laufendes Jahr: +27,4%

>REZOLUTE Aktie

Name:

REZOLUTE INC. NEW DL-,001

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US76200L3096 / A2QEWP

Symbol/ Ticker:

6HV1 (Frankfurt) / RZLT (NASDAQ)

Kürzel:

FRA:6HV1, ETR:6HV1, 6HV1:GR, NASDAQ:RZLT

Index:

Webseite:

https://rezolutebio.com/

Profil:

Rezolute, Inc. is a late-stage rare disease company focused on developing therapies to improve outcomes for individuals with hypoglycemia caused by hyperinsulinism, including congenital and tumor forms. Its lead clinical asset, ersodetug, is an intra..
>Volltext..

Marktkapitalisierung:

235.82 Mio. EUR

Unternehmenswert:

124.72 Mio. EUR

Umsatz:

EBITDA:

-77.71 Mio. EUR

Nettogewinn:

-72.83 Mio. EUR

Gewinn je Aktie:

-0.8 EUR

Schulden:

1.11 Mio. EUR

Liquide Mittel:

10.33 Mio. EUR

Operativer Cashflow:

-66.71 Mio. EUR

Bargeldquote:

13.95

Umsatzwachstum:

Gewinnwachstum:

-4.37%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

1 Insider kaufte innerhalb der letzten 30 Tage Aktien im Wert von 28.500 USD.

Suchwörter:

REZOLUTE

Letzte Datenerhebung:

02.04.26

>REZOLUTE Kennzahlen

Aktien/ Unternehmen:

Aktien: 95.7 Mio. St.

Frei handelbar: 87.64%

Leerverk. Aktien: 17.7%

Rückkaufquote: -37.56%

Mitarbeiter: 71

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Buy

Kursziel: 56.94%

Bewertung:

KGV: -

KGV lG: -

KUV: -

KBV: 2.54

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -67.21%

Eigenkaprendite: -74.02%

>REZOLUTE Peer Group

Gesundheit, Diabetes- & Adipositas- Behandlung, Antikörper- Behandlung, Zell- & Gentherapie/ Gentechnik/ Erbkrankheiten

>REZOLUTE Chart & Kurs - NASDAQ

>REZOLUTE News

01.04.26 - 02:01	Insiderhandel: CFO kauft Aktien von Rezolute im Wert von 28500 USD (Insiderkauf)
	Evans, Daron - Vorstand - Tag der Transaktion: 2026-03-30...

25.03.26 - 16:30	Rezolute Stock Gains After FDA Meeting on Ersodetug Program Update (Zacks)
	RZLT stock jumps 12% after an FDA meeting highlights ersodetug data and next steps, despite an earlier phase III setback in the congenital HI study....

24.03.26 - 19:42	FDA Review Puts Rezolute′s Genetic Disorder Drug Path In Question (Benzinga)
	Rezolute shares rise after FDA feedback on sunRIZE trial; mixed efficacy, data review ahead for rare genetic disorder drug. Importance Rank: 1 read more...

24.03.26 - 16:00	Rezolute gains after positive FDA meeting over lead asset (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

24.03.26 - 12:03	Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting (GlobeNewswire EN)
	FDA encourages the Company to submit comprehensive data from sunRIZE and the ongoing open-label extension to inform next steps for the program FDA encourages the Company to submit comprehensive data from sunRIZE and the ongoing open-label extension to inform next steps for the program...

05.03.26 - 15:48	INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (RZLT) (PR Newswire)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options If you suffered significant losses in Rezolute stock or options and would like to discuss your legal......

04.03.26 - 13:03	Rezolute to Participate in the Citizens Life Sciences Conference (GlobeNewswire EN)
	REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism (HI), today announced that management will participate in the Citizens Life Sciences Conference, taking place March 10-11, 2026, in Miami, FL....

28.02.26 - 13:09	RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (PR Newswire)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options If you suffered significant losses in Rezolute stock or options and would like to discuss your legal......

13.02.26 - 16:15	INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (PR Newswire)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options If you suffered significant losses in Rezolute stock or options and would like to discuss your legal......

12.02.26 - 22:42	Rezolute GAAP EPS of -$0.22 misses by $0.03 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.02.26 - 22:09	Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update (GlobeNewswire EN)
	REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism (HI), today reported financial results and provided a business update for the three months ended December 31, 2025....

07.02.26 - 14:27	INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (PR Newswire)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options If you suffered significant losses in Rezolute stock or options and would like to discuss your legal......

04.02.26 - 13:03	Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 (GlobeNewswire EN)
	REDWOOD CITY, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism (HI), today announced that management will participate in the Guggenheim Emerging Outlook: Biotech Summit 2026, taking place February 11-12, 2026 in New York....

29.01.26 - 14:36	SHAREHOLDER INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (PR Newswire)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options If you suffered significant losses in Rezolute stock or options and would like to discuss your legal......

26.01.26 - 02:24	INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (PR Newswire)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options If you suffered significant losses in Rezolute stock or options and would like to discuss your legal......

17.01.26 - 16:51	DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (PR Newswire)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options If you suffered significant losses in Rezolute stock or options and would like to discuss your legal......

15.01.26 - 16:01	INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT (PR Newswire)
	NEW YORK, Jan. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rezolute, Inc. ("Rezolute" or the "Company") (NASDAQ: RZLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation......

14.01.26 - 18:01	Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating (PR Newswire)
	Partner Reed Kathrein Urges Investors to Contact Firm SAN FRANCISCO, Jan. 14, 2026 /PRNewswire/ -- On December 11, 2025, investors in Rezolute, Inc. (NASDAQ: RZLT) saw the price of their shares crater as much as 90% during intraday trading after the company revealed the failure of its......

14.01.26 - 15:42	Levi & Korsinsky, LLP: RZLT ALERT: Levi & Korsinsky Investigates Rezolute, Inc. for Possible Securities Fraud Violations (Newsfile)
	New York, New York--(Newsfile Corp. - January 14, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Rezolute, Inc. ("Rezolute, Inc.") (NASDAQ: RZLT) concernin......

13.01.26 - 23:18	Faruqi & Faruqi LLP: RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (Newsfile)
	Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their OptionsIf you suffe......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Don′t marry, be happy. - Hera Lind

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram